GT BIOPHARMA, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
GT BIOPHARMA, INC. (GTBP) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $18.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-13.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2020-11-13
- 2020-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $18.00K.
- 2020-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $36.00K.
- 2020-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $53.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2020-09-30 | $18.00K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $36.00K 10-Q/A · filed 2020-08-18 |
| 2020-03-31 | $53.00K 10-Q · filed 2020-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |